Deutsche Bank’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,316
| Closed | -$39K | – | 4381 |
|
|
2022
Q1 | $39K | Sell |
3,316
-372
| -10% | -$6.65K | ﹤0.01% | 3913 |
|
|
2021
Q4 | $120K | Sell |
3,688
-2,309
| -39% | -$93.5K | ﹤0.01% | 3629 |
|
|
2021
Q3 | $268K | Buy |
5,997
+2,381
| +66% | +$116K | ﹤0.01% | 3415 |
|
|
2021
Q2 | $196K | Sell |
3,616
-2,003
| -36% | -$119K | ﹤0.01% | 3800 |
|
|
2021
Q1 | $420K | Buy |
5,619
+2,513
| +81% | +$261K | ﹤0.01% | 3213 |
|
|
2020
Q4 | $337K | Buy |
3,106
+802
| +35% | +$73.2K | ﹤0.01% | 3164 |
|
|
2020
Q3 | $204K | Buy |
2,304
+201
| +10% | +$22.8K | ﹤0.01% | 3202 |
|
|
2020
Q2 | $224K | Buy |
2,103
+913
| +77% | +$82K | ﹤0.01% | 3090 |
|
|
2020
Q1 | $70K | Sell |
1,190
-725
| -38% | -$49.2K | ﹤0.01% | 3400 |
|
|
2019
Q4 | $131K | Sell |
1,915
-3,917
| -67% | -$238K | ﹤0.01% | 3453 |
|
|
2019
Q3 | $604K | Sell |
5,832
-3,249
| -36% | -$307K | ﹤0.01% | 2582 |
|
|
2019
Q2 | $838K | Buy |
9,081
+6,107
| +205% | +$425K | ﹤0.01% | 2961 |
|
|
2019
Q1 | $269K | Sell |
2,974
-1,601
| -35% | -$112K | ﹤0.01% | 3823 |
|
|
2018
Q4 | $254K | Sell |
4,575
-2,933
| -39% | -$223K | ﹤0.01% | 3744 |
|
|
2018
Q3 | $894K | Sell |
7,508
-13,343
| -64% | -$1.55M | ﹤0.01% | 3412 |
|
|
2018
Q2 | $2.13M | Buy |
20,851
+18,857
| +946% | +$2.34M | ﹤0.01% | 2910 |
|
|
2018
Q1 | $258K | Sell |
1,994
-767
| -28% | -$83.9K | ﹤0.01% | 4061 |
|
|
2017
Q4 | $267K | Sell |
2,761
-788
| -22% | -$106K | ﹤0.01% | 3895 |
|
|
2017
Q3 | $520K | Buy |
3,549
+2,081
| +142% | +$391K | ﹤0.01% | 3400 |
|
|
2017
Q2 | $234K | Buy |
1,468
+1,353
| +1,177% | +$213K | ﹤0.01% | 3846 |
|
|
2017
Q1 | $18K | Sell |
115
-190
| -62% | -$23.2K | ﹤0.01% | 4534 |
|
|
2016
Q4 | $35K | Buy |
+305
| New | +$42.8K | ﹤0.01% | 4449 |
|
Other funds holding SYRS
BCLSI
AG
ABG
FP
OFM
SB
